Radiographic patterns of first disease recurrence after neoadjuvant therapy and surgery for patients with resectable and borderline resectable pancreatic cancer
Author:
Funder
Medical College of Wisconsin Department of Surgery
WeCare Fund for Medical Innovation and Research
Ronald Burkland Eich Pancreatic Cancer Research Fund
Advancing a Healthier Wisconsin Fund
Publisher
Elsevier BV
Subject
Surgery
Reference40 articles.
1. DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer;Iacobuzio-Donahue;J Clin Oncol,2009
2. Patterns of recurrence after curative resection of pancreatic cancer, based on autopsy findings;Hishinuma;J Gastrointest Surg,2006
3. Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: the CONKO-001 randomized trial;Oettle;JAMA,2013
4. and the European Study Group for Pancreatic Cancer. Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial;Neoptolemos;Lancet,2017
5. Adjuvant Therapy in Pancreas Cancer: Does It Influence Patterns of Recurrence?;Parikh;J Am Coll Surg,2016
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Relationships between postoperative recurrences and standardized uptake value on 18F-fluorodeoxyglucose-positron emission tomography in patients with resectable and borderline resectable pancreatic ductal adenocarcinoma who underwent curative pancreatic resection after neoadjuvant chemoradiotherapy;Pancreatology;2024-08
2. Prognostication for recurrence patterns after curative resection for pancreatic ductal adenocarcinoma;Annals of Hepato-Biliary-Pancreatic Surgery;2024-04-01
3. Long‐term outcomes of neoadjuvant gemcitabine, nab‐paclitaxel, and S1 (GAS) in borderline resectable pancreatic cancer with arterial contact: Results from a phase II trial;Journal of Hepato-Biliary-Pancreatic Sciences;2023-12-29
4. No survival benefit with suboptimal CA19-9 response: defining effective neoadjuvant chemotherapy in resectable or borderline resectable pancreatic cancer;HPB;2023-05
5. Impact of margin accentuation with intraoperative irreversible electroporation on local recurrence in resected pancreatic cancer;Surgery;2023-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3